Dr. Reddys Laboratories (RDY)
(Real Time Quote from BATS)
$13.96 USD
-0.34 (-2.38%)
Updated Nov 21, 2024 03:36 PM ET
2-Buy of 5 2
B Value D Growth D Momentum C VGM
Price, Consensus and EPS Surprise
RDY 13.96 -0.34(-2.38%)
Will RDY be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for RDY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RDY
Dr. Reddy's Q2 Earnings Miss Estimates, Global Generics Revenues Grow
Here's Why Doctor Reddy's (RDY) is a Strong Value Stock
RDY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Dr. Reddy's (RDY), Kainomyx Sign Potential Deal for Malaria Drug
Dr. Reddy's (RDY) Q1 Earnings Miss Estimates, Revenues Beat
Dr. Reddy's (RDY) to Acquire Haleon's Nicotine Addiction Drug
Other News for RDY
Dr. Reddy’s Receives USFDA Observations Post Inspection
Wilsons Sticks to Its Buy Rating for ReadyTech Holdings Ltd. (RDY)
Dr. Reddy’s Gains Strong Rating Amid Robust Growth
ReadyTech Holdings Sees Strong Approval at AGM
ReadyTech Holdings Updates at 2024 AGM